Skip to content
Menu

Cullinan Therapeutics, Inc. CGEM

Full chart Compare
Set alert

Price alert · CGEM

All alert types
8.61 USD -0.89 (-9.42%)

As ofNov 17, 2026, 2:25 PM EST

8.48 Day range 9.45
8.23 52-week range 23.19
YTD
-16.86%
1 year
-1.88%

CGEM free cash flow history

Free cash flow is operating cash flow minus capital expenditure outflow. It can be negative; it is not the same as earnings.

-175,799,000 USD

FY 2025 · Period ended

Coverage: complete. Values in USD; not inflation adjusted.

Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.

Capital expenditure here is net of asset disposals, so free cash flow can be higher than a figure that subtracts gross purchases.

Scroll the table to see all values →

Free cash flow · annual · USD
Fiscal periodPeriod endFree cash flowYoY changeYoY %
FY 20252025-12-31-175,799,000-30,496,000Not meaningful
FY 20242024-12-31-145,303,000-10,820,000Not meaningful
FY 20232023-12-31-134,483,000-6,777,000Not meaningful
FY 20222022-12-31-127,706,000-84,273,000Not meaningful
FY 20212021-12-31-43,433,000-13,651,000Not meaningful
FY 20202020-12-31-29,782,000-8,865,000Not meaningful
FY 20192019-12-31-20,917,000-7,107,000Not meaningful
FY 20182018-12-31-13,810,000Not availableNot available

Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.

Company-reported financial statements. Retrieved 2026-05-22T14:43:12.000Z. Retrieval time is not a report date.

Open full statements

Use Add to watchlist above to save this stock.